Skip to main content
CTOS 2024 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Bernd Kasper, MD, PhD (he/him/his)

Medical Director Mannheim Cancer Center (MCC)
University of Heidelberg, Mannheim University Medical Center, Mannheim Cancer Center (MCC)
Mannheim, Baden-Wurttemberg, Germany

Prof. Bernd Kasper studied Medicine at the University of Heidelberg and received his MD degree from Heidelberg University in 2000. In 2001, he finalised his thesis at the German Cancer Research Centre (DKFZ) in Heidelberg. To deepen his training, he stayed in London (Imperial College School of Medicine), Brussels (Jules Bordet Institute) and South Kerala, India. In 2007/2008, he specialized in Internal Medicine and Medical Haematology/Oncology at the Department of Internal Medicine V at the University of Heidelberg. Currently, he is leading the the Mannheim Cancer Center (MCC) at the Mannheim University Medical Center, University of Heidelberg. Prof. Kasper has a lifetime professional dedication to patient care and research in soft tissue sarcomas (STS), desmoid-type fibromatosis (DF) and gastrointestinal stromal tumors (GIST). His clinical practice focuses exclusively on these disease entities. He is head of the study center of the German Interdisciplinary Sarcoma Group (GISG) and is active in national and international study groups (AIO, EORTC). He is the Principal Investigator of several national and international trials on STS, DF and GIST. Currently, he serves as the Past-Chair of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) and is Outreach Chair of the Connective Tissue Oncology Society (CTOS). Prof. Kasper has authored more than 100 scientific publications. He is dedicated as board member to patient organizations dealing with STS, DF and GIST on the national and international level such as SPAGN, NLMSF and DTRF.

Disclosure information not submitted.

Presentation(s):

Email Bernd